Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • IQVIA AI Assistant
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Meet the IQVIA AI Assistant

Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
How will the EU Pharmaceutical revision impact you?
Aurelio Arias, Director, EMEA Thought Leadership
Per Troein, Vice President, Supplier Services
Richard Bergström, Vice President, European Affairs
Sarah Rickwood, Vice President, EMEA Thought Leadership
Aug 18, 2023
  • Locations
  • EMEA
  • How will the EU Pharmaceutical revision impact you?

New White Paper Available: EU Revision of the Pharmaceutical Legislation. To request access, email thoughtleadershipgroup@iqvia.com

On 26 April 2023, the European Commission proposed their long-awaited revisions to the EU’s pharmaceutical legislation aimed at making medicines more available, accessible and affordable. We analysed five of the more contentious proposals, applying IQVIA’s unique data and insights to explore their impact on life science companies, payers and, ultimately, evaluate the extent at which the Commission’s proposals may shake up European healthcare.

The five areas are:

  1. Reliance on Regulatory Data Protection (RDP). These changes, see Figure 1, need to be looked at in combination with the wider EU Pharmaceutical Strategy for a full assessment. Companies will be impacted differently, depending on their portfolio. We provide an analysis on what this means for different stakeholders.
  2. Changes to orphan medicines. There may be a smaller consequence on how orphan medicines are brought to market. We go into details in the report.
  3. Access across all EU member states within two (or three) years. IQVIA believes that launching within two years is not possible under the current decentralised system.
  4. Transferrable anti-microbial resistance (AMR) vouchers. We discuss the voucher’s potential as an incentive and propose a hybrid purchasing framework instead.
  5. Incentives for the repurposing of medicines. Finally, repurposed medicines are in the spotlight. But will these changes be enough to allow them to gain a price premium?

How can you prepare?

Although this proposal will likely undergo change and not be implemented until the second half of this decade, it is important to engage in this conversation early and calculate its impact on your organisation.

These are the essential steps IQVIA recommends to ensure you are ready:

  • Understand the impact the proposal changes will have on your portfolio and future acquisition strategy
  • Pressure test launching across all EU member states, evaluating supply needs and building launch capabilities
  • Find partners able to support launching in EU member states
  • Calculate what value the AMR vouchers could have for your organisation
  • Evaluate repurposing opportunities to capitalise on new RDP incentives

Want to find out more?

To request the full white paper with deeper analyses, or if you would like IQVIA to profile how this proposal may impact you, please reach out to your IQVIA representative or directly to thoughtleadershipgroup@iqvia.com

You may also be interested in

Case Study
Enhancing Clinical Development Plan and Regulatory Support for Small Emerging Biopharma in Neuroma Therapy
Presentation
Belgian Retail Market
Presentation
Luxembourg Retail Market
Case Study
Improving Affordability, Access and Adherence with a Customized Patient Engagement Technology
Video
C-suite Interview Series: Consumer Health
Infographic
Recover, Rebuild and Revive: 5 Key Capabilities for Building a COVID-19 Resilient Pharma Organization
Prev
Next

Related solutions

Industry Segments

See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.

MIDAS®

Analyze industry leading sales and medical data in a standardized and comparable way, including cross-country analysis of performance and additional insights into global and regional markets.

Market Measurement

Get an up to date view of key performance indicators globally, regionally, or locally.

Commercialization

Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.

Contact Us